Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia

A. Bellomo Damato, G. Stefanelli, L. Laviola, R. Giorgino and F. Giorgino

Diabetic Medicine 28 ( 5 ): 560 - 566 , 2011